LabCorp 2015 Annual Report Download - page 45

Download and view the complete annual report

Please find page 45 of the 2015 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 151

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151

Index
occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates
of the aggregated liability of claims incurred. At December 31, 2015, the Company had provided letters of credit aggregating approximately $45.4 million,
primarily in connection with certain insurance programs. The Company’s availability under its Revolving Credit Facility is reduced by the amount of these
letters of credit.
 
Not applicable.

           


The Company's common stock, par value $0.10 per share (Common Stock), trades on the New York Stock Exchange (NYSE) under the symbol “LH.” The
following table sets forth for the calendar periods indicated the high and low sales prices for the Common Stock reported on the NYSE Composite Tape.
High
Low

First Quarter $ 102.00
$ 87.25
Second Quarter $ 105.38
$ 95.12
Third Quarter $ 108.77
$ 101.55
Fourth Quarter $ 109.84
$ 95.61

First Quarter $ 131.19
$ 108.73
Second Quarter $ 129.33
$ 116.00
Third Quarter $ 128.84
$ 105.77
Fourth Quarter $ 126.24
$ 107.30

On February 23, 2016, there were 101.7 million holders of record of the Common Stock.

The transfer agent for the Company's Common Stock is American Stock Transfer & Trust Company, Shareholder Services, 6201 Fifteenth Avenue,
Brooklyn, NY 11219, telephone: 800-937-5449, website: www.amstock.com.

The Company has not historically paid dividends on its Common Stock and does not presently anticipate paying any dividends on its Common Stock in
the foreseeable future.

The Company’s common stock is traded on the NYSE. The graph below shows the cumulative total return assuming an investment of $100 on December
31, 2010 in each of the Company’s common stock, the Standard & Poor’s (S&P) Composite-500 Stock Index and the S&P 500 healthcare Index (Peer Group)
and assuming that all dividends were reinvested.
45